leapcure image ad
See all leapcure ads →
Sep 28, 2026
Facing a relapse after treatment for AITL or TFH-type lymphoma? You may be eligible for a new research study evaluating an or...
research.leapcure.com
Oral Treatment Being Researched for Refractory Lymphoma
Reach
47.5K
Est. spend
$712.7
Ran for
12d
Format
dco
Platforms
A world of creative inspiration
Your next great ad
starts with an idea.
Explore 13.5M+ ads in Admanage. Find fresh angles, follow the brands that inspire you, and save your next campaign’s starting point.
Join Admanage
Discover new ideasBuild your swipe fileExplore brands you love